½ÃÀ庸°í¼­
»óǰÄÚµå
1701905

°£Çæ Ä«Å×ÅÍ ½ÃÀå : Á¦Ç°º°, ÀûÀÀÁõº°, Ä«Å×°í¸®º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Intermittent Catheters Market Report by Product, Indication (Urinary Incontinence, Surgery, Spinal Cord Injury, and Others), Category, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 139 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°£Çæ Ä«Å×ÅÍ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 29¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 49¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 5.72%¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÀÇ·á º¸Çè Àû¿ë ¹üÀ§ È®´ë, Ä«Å×ÅÍ »ðÀÔÀÌ ÇÊ¿äÇÑ ¼ö¼ú °Ç¼ö Áõ°¡, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, Ä«Å×ÅÍ ¼³°èÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, ³ëÀÎ Àα¸ÀÇ Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

°£Çæ Ä«Å×ÅÍ »ðÀÔ¼úÀº ¹æ±¤¿¡¼­ ¼Òº¯À» ¹èÃâÇϱâ À§ÇØ Ä«Å×Å͸¦ »ðÀÔÇϰí Á¦°ÅÇÏ´Â ½Ã¼úÀÔ´Ï´Ù. Ư¹ß¼º ¶Ç´Â ½Å°æÀμº ¹æ±¤ °úȰµ¿¼º(NDO) ±â´É Àå¾Ö, ¿°Áõ, ½Å°æÇÐÀû »óÅÂ, ¾à¸®ÇÐÀû ¾à¹°, ¹°¸®Àû ¹æ±¤Æó»ö µîÀ¸·Î ÀÎÇØ ºÒ¿ÏÀüÇÑ ¹æ±¤ ¹è´¢¸¦ º¸À̴ ȯÀÚ¿¡°Ô È¿°úÀûÀÎ ¹æ±¤ °ü¸® Àü·«ÀÔ´Ï´Ù. ¹æ±¤ ÆØÃ¢°ú ¿ä·Î°¨¿°(UTI)À» ¿¹¹æÇϸ鼭 »ç¿ëÇϱ⠽±°í Æí¸®ÇÕ´Ï´Ù. ¶ÇÇÑ ´©Ãâ, ¸·Èû, ¹æ±¤ °æ·ÃÀ» ÇÇÇÒ ¼ö Àֱ⠶§¹®¿¡ °£Çæ Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°£Çæ Ä«Å×ÅÍ ½ÃÀå µ¿Çâ:

ÇöÀç Àü ¼¼°èÀûÀ¸·Î ¿ä·Î°¨¿°Áõ(UTI) ¹× ¿äµµÆó»öÀ¸·Î °íÅë¹Þ´Â ȯÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¿ä·Î ¹× »ý½Ä ±â°üÀÇ Á¾¾ç Áõ°¡¿Í ÇÔ²² ½ÃÀåÀ» À̲ô´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ¹æ±¤¿°, Àü¸³¼± ºñ´ëÁõ, ½ÅÀå °á¼®°ú °°Àº ºñ´¢±â ÁúȯÀÇ À¯º´·üÀÌ ´ëÁßµé »çÀÌ¿¡¼­ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ô¼ö ¼Õ»ó, ´Ù¹ß¼º °æÈ­Áõ, Ä¡¸Å µî ´Ù¾çÇÑ Áúȯ¿¡¼­ °£Çæ Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î »ê¾÷°ú ÇÔ²² ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ Àû±ØÀûÀ¸·Î ÅõÀÚÇϰí ÀÖÀ¸¸ç, 2Â÷ °¨¿°À¸·ÎºÎÅÍÀÇ º¸È£¸¦ °­È­Çϱâ À§ÇØ ¿Âµµ ¸ð´ÏÅ͸µ ±â´ÉÀÌ ÀÖ´Â ÄÚÆÃµÈ ¿äµµ Ä«Å×Å͸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä¡·á¸¦ À§ÇØ ÀÇ·á±â°üÀ» ¹æ¹®ÇÒ ¼ö ¾ø´Â ȯÀÚµéÀ» À§ÇØ ¿Â¶óÀÎ »ó´ã ¹× ¾È³»¸¦ Á¦°øÇÏ´Â Ç÷§Æûµµ Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, Ä£¼ö¼º Ç×±Õ °£Çæ Ä«Å×ÅÍ¿Í °°Àº »õ·Î¿î Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2024³â ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð´Â?
  • 2025-2033³â ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ Àü ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ Á¦Ç°º° ºÐ·ù´Â?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ÀûÀÀÁõº° ºÐ·ù´Â?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ Ä«Å×°í¸®º° ºÐ·ù´Â?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ÃÖÁ¾»ç¿ëÀÚº° ºÐ¼®Àº?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾î/±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • ºñÄÚÆÃ °£Çæ Ä«Å×ÅÍ
  • ÄÚÆÃ °£Çæ Ä«Å×ÅÍ
    • ÁÖ¿ä ºÎ¹®
    • Ç×±Õ¼º
    • Ä£¼ö¼º
    • ±âŸ

Á¦7Àå ½ÃÀå ³»¿ª : ÀûÀÀÁõº°

  • ¿ä½Ç±Ý
  • ¼ö¼ú(ÁÖ¿ä ¼ö¼ú)
  • ô¼ö ¼Õ»ó
  • ±âŸ

Á¦8Àå ½ÃÀå ³»¿ª : Ä«Å×°í¸®º°

  • ³²¼º¿ë Ä«Å×ÅÍ
  • ¾Æµ¿¿ë Ä«Å×ÅÍ
  • ¿©¼º¿ë Ä«Å×ÅÍ

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ÀÇ·á ¿¬±¸ ¼¾ÅÍ
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå ³»¿ª : ±¹°¡º°

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • B. Braun Melsungen AG
    • Becton Dickinson and Company
    • Coloplast A/S
    • Cure Medical LLC(Convatec Group plc)
    • Hollister Incorporated
    • Hunter Urology
    • Medical Technologies of Georgia Inc.
    • Pennine Healthcare Ltd.
    • Teleflex Inc
    • Wellspect Limited(Dentsply Sirona)
ksm

The global intermittent catheters market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033. The market is majorly driven by the expansion of healthcare insurance coverage, increasing number of surgeries requiring catheterization, rising preference for minimally invasive procedures, growing prevalence of neurological disorders, rapid technological advancements in catheter design, and the increasing geriatric population.

Intermittent catheterization is a procedure of inserting and removing a catheter to drain urine from a bladder. It is an effective bladder management strategy for patients with incomplete bladder emptying due to idiopathic or neurogenic detrusor overactivity (NDO) dysfunction, inflammation, neurological conditions, pharmacological agents, and physical bladder obstruction. It is easy to use and convenient while preventing a distended bladder or a urinary tract infection (UTI). Besides this, as it avoids leaking, blockage, and bladder spasms, the demand for intermittent catheters are increasing across the globe.

Intermittent Catheters Market Trends:

At present, there is a rise in the number of patients suffering from urinary tract infections (UTIs) and blockages in the urethra around the world. This, along with the growing incidences of tumors in the urinary tract or reproductive organs, represents one of the key factors driving the market. Moreover, the rising prevalence of urological disorders, such as cystitis, benign prostatic hyperplasia, and kidney stones, among the masses is offering lucrative growth opportunities to industry investors. Besides this, there is an increase in the demand for intermittent catheters in various medical conditions, such as spinal cord injury, multiple sclerosis, or dementia. This, coupled with the burgeoning healthcare industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce coated urine catheters with temperature monitoring for enhanced protection against secondary infections. They are also launching platforms for providing online counseling and guidance to patients who cannot visit healthcare facilities for treatment. Apart from this, the escalating demand for novel catheters, such as hydrophilic antimicrobial intermittent catheters, is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Product:

  • Uncoated Intermittent Catheter
  • Coated Intermittent Catheter
  • Antimicrobial
  • Hydrophilic
  • Others

Breakup by Indication:

  • Urinary Incontinence
  • Surgery (Major Surgery)
  • Spinal Cord Injury
  • Others

Breakup by Category:

  • Male Length Catheter
  • Kids Length Catheter
  • Female Length Catheter

Breakup by End User:

  • Hospitals
  • Medical Research Centers
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Coloplast A/S, Cure Medical LLC (Convatec Group plc), Hollister Incorporated, Hunter Urology, Medical Technologies of Georgia Inc., Pennine Healthcare Ltd., Teleflex Inc and Wellspect Limited (Dentsply Sirona).

Key Questions Answered in This Report

  • 1.What was the size of the global intermittent catheters market in 2024?
  • 2.What is the expected growth rate of the global intermittent catheters market during 2025-2033?
  • 3.What are the key factors driving the global intermittent catheters market?
  • 4.What has been the impact of COVID-19 on the global intermittent catheters market?
  • 5.What is the breakup of the global intermittent catheters market based on the product?
  • 6.What is the breakup of the global intermittent catheters market based on the indication?
  • 7.What is the breakup of the global intermittent catheters market based on category?
  • 8.What is the breakup of the global intermittent catheters market based on the end user?
  • 9.What are the key regions in the global intermittent catheters market?
  • 10.Who are the key players/companies in the global intermittent catheters market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intermittent Catheters Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Uncoated Intermittent Catheter
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Coated Intermittent Catheter
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
    • 6.2.1 Antimicrobial
    • 6.2.2 Hydrophilic
    • 6.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Urinary Incontinence
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surgery (Major Surgery)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spinal Cord Injury
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Category

  • 8.1 Male Length Catheter
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Kids Length Catheter
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Female Length Catheter
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Medical Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Coloplast A/S
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cure Medical LLC (Convatec Group plc)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Hollister Incorporated
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Hunter Urology
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Medical Technologies of Georgia Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pennine Healthcare Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Teleflex Inc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Wellspect Limited (Dentsply Sirona)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦